Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 4004 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

FDA places hold on Threshold trial

These abnormalities include three serious adverse events observed at three months of dosing in the phase III European/Canadian clinical trial and three additional observations of elevated liver enzymes

FDA fast tracks Biovest’s lymphoma drug

The targeted anticancer immunotherapy is now undergoing pivotal phase III clinical trials at over 20 major medical centers throughout the US. The drug showed very positive phase II

AlphaRx collaborates with PharmaSeed on CNS drugs

Under the collaboration, AlphaRx will be responsible for the synthesis, characterization, formulation, analysis and production of this new class of compounds, which PharmaSeed will evaluate in stroke and

Researchers find new treatment for food poisoning

The group, led by Professor Jose Vazquez-Boland, has shown that fosfomycin can treat listeria in the body, despite it being ineffective in laboratory conditions. The researchers’ findings were